Kopran P/E Ratio
Kopran (KOPRAN) P/E ratio is 45.58 (High), EPS (TTM) ₹5.33, current price ₹277.60 on NSE vs historical average P/E of 16.39 (100.0th percentile) — Very High - High growth expectations or significantly overvalued.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
KOPRAN P/E Ratio — Valuation Signal & Historical Context
Kopran P/E 45.58 vs historical average 16.39, range 2.62–42.82 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Kopran share price screener.
- Stock appears overvalued with PE of 45.58, suggesting caution for new investments
- Current PE is 178.1% above historical average
- Trading at discount to sector average PE of 56.79
Kopran P/E Ratio Historical Trend
KOPRAN annual price-to-earnings ratio — 9 years, EPS and year-end price. Current P/E 45.58 vs historical average 16.39. Also explore KOPRAN stock price history to track price trends across different timeframes.
KOPRAN Historical P/E Ratio — EPS, Year-End Price & Valuation
Kopran annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 25.49 | 9.85 | ₹251.10 | NSE | High |
| 2023 | 17.76 | 8.39 | ₹149.00 | NSE | Moderate |
| 2022 | 42.82 | 7.67 | ₹328.40 | NSE | High |
| 2021 | 10.25 | 13.54 | ₹138.85 | NSE | Low |
| 2020 | 2.62 | 11.87 | ₹31.15 | NSE | Low |
| 2019 | 7.05 | 5.5 | ₹38.80 | NSE | Low |
| 2018 | 13.75 | 4.96 | ₹68.20 | NSE | Low |
| 2017 | 10.68 | 4.95 | ₹52.85 | NSE | Low |
| 2016 | 17.09 | 4.41 | ₹75.35 | NSE | Moderate |
KOPRAN vs Healthcare Peers — P/E Ratio Comparison
Kopran P/E 45.58 vs Healthcare average 56.79, median 31.66 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |